Shein Shares Slide 9% in Hong Kong IPO Debut 
Lynas Rare Earths Shares Rise After Takeover Talks Revealed 
GM Canada Workers Approve C$1.1 Billion Investment Deal 
OpenAI Rejects Apple Trade Secret Theft Claims 
MongoDB Stock Sinks 14% as Atlas Growth Misses Expectations 
Aon Nears $17 Billion Deal to Buy USI Insurance From KKR 
Lenovo Shares Fall After Dropbox Security Breach Exposes ID Vulnerability 
MediaTek Shares Jump 10% on Nvidia’s $3.5 Billion Investment 
Audi, SAIC Launch China Innovation Hub for New AUDI Models 
Shein Shares Drop 5% After Weak Hong Kong IPO Debut 
Trump Says ExxonMobil Among Oil Majors Planning Venezuela Return 
SpaceX Mobile Network Could Cost Up to $130 Billion, Bernstein Says 
Honda Targets $9.4 Billion in Cost Cuts as China EV Competition Intensifies 
Apple’s Phil Schiller Steps Back as Leadership Shake-Up Accelerates 
Star Entertainment Shares Fall After A$307 Million FY2026 Loss 
Thomson Reuters C-Track Cyberattack Hits Courts Across U.S. and Canada 
CIA-Linked Investor Helped Quantum Systems Expand in US 
Add as a preferred source on Google
DOYLESTOWN, Pa., March 16, 2018 -- ProPhase Labs (NASDAQ:PRPH) announced today that financial results for the year ended December 31, 2017, will be released before the market opens on Wednesday, March 21, 2018. A conference call will be held on Wednesday March 21, at 11:00 a.m. EST. ProPhase Labs Chairman and CEO, Ted Karkus will provide a company overview including a review of activities and year end results. There will be a question and answer session following initial remarks.
The conference call will be webcast live at:
https://engage.vevent.com/rt/prophaselabsinc_ao~6285328 at 11:00 a.m. (EST) on Wednesday, March 21, 2018.
Participants wishing to ask questions may access the live call by dialing 833-623-9017 conference ID # 6285328. A replay of the conference call will be available for 90 days on the company website www.ProPhaseLabs.com.
About the Company
We are a vertically integrated and diversified branding, marketing and technology company with deep experience with over-the-counter (“OTC”) consumer healthcare products, dietary supplements and other remedies. We are engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products, dietary supplements and other remedies in the United States. This includes the development and marketing of dietary supplements under the TK Supplements® brand, a wholly-owned subsidiary of the Company.
In August 2017, we formed a new, additional wholly-owned subsidiary, ProPhase Digital Media, Inc., a Delaware corporation (“PDM”). Our objective is for PDM to become an independent full-service direct marketing agency. PDM’s first initiative will be to market the TK Supplements® product line. If successful, this may lead to the marketing of other company’s consumer products.
In addition, the Company also continues to actively pursue acquisition opportunities for other companies, technologies and products inside and outside the consumer products industry.
Investor Contact
Ted Karkus, Chairman and CEO
ProPhase Labs, Inc.
(267) 880-1111
